Proteona has announced that it is beginning a partnership with Professor Nikolai Petrovsky from Flinders University to characterize the clinical response to a new SARS-CoV-2 vaccine.
PixVC provides early-stage venture capital to startups in the areas of Info-Tech, Med-Tech and Eco-Tech.